117 related articles for article (PubMed ID: 16364538)
21. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
22. A molecular dissection of the glycoprotein hormone receptors.
Vassart G; Pardo L; Costagliola S
Trends Biochem Sci; 2004 Mar; 29(3):119-26. PubMed ID: 15003269
[TBL] [Abstract][Full Text] [Related]
23. The hinge region: an important receptor component for GPHR function.
Mueller S; Jaeschke H; Günther R; Paschke R
Trends Endocrinol Metab; 2010 Feb; 21(2):111-22. PubMed ID: 19819720
[TBL] [Abstract][Full Text] [Related]
24. Functional and structural roles of conserved cysteine residues in the carboxyl-terminal domain of the follicle-stimulating hormone receptor in human embryonic kidney 293 cells.
Uribe A; Zariñán T; Pérez-Solis MA; Gutiérrez-Sagal R; Jardón-Valadez E; Piñeiro A; Dias JA; Ulloa-Aguirre A
Biol Reprod; 2008 May; 78(5):869-82. PubMed ID: 18199880
[TBL] [Abstract][Full Text] [Related]
25. Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Sep; 144(9):3821-7. PubMed ID: 12933653
[TBL] [Abstract][Full Text] [Related]
26. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling.
Latif R; Morshed SA; Zaidi M; Davies TF
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):319-41, viii. PubMed ID: 19328414
[TBL] [Abstract][Full Text] [Related]
27. Insights into differential modulation of receptor function by hinge region using novel agonistic lutropin receptor and inverse agonistic thyrotropin receptor antibodies.
Majumdar R; Railkar R; Dighe RR
FEBS Lett; 2012 Mar; 586(6):810-7. PubMed ID: 22309849
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface.
Kleinau G; Jäschke H; Neumann S; Lättig J; Paschke R; Krause G
J Biol Chem; 2004 Dec; 279(49):51590-600. PubMed ID: 15345720
[TBL] [Abstract][Full Text] [Related]
29. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource.
Kleinau G; Brehm M; Wiedemann U; Labudde D; Leser U; Krause G
Mol Endocrinol; 2007 Feb; 21(2):574-80. PubMed ID: 17110401
[TBL] [Abstract][Full Text] [Related]
30. Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome.
De Leener A; Caltabiano G; Erkan S; Idil M; Vassart G; Pardo L; Costagliola S
Hum Mutat; 2008 Jan; 29(1):91-8. PubMed ID: 17721928
[TBL] [Abstract][Full Text] [Related]
31. Identification of TSH receptor mutations in three families with resistance to TSH.
Tonacchera M; Di Cosmo C; De Marco G; Agretti P; Banco M; Perri A; Gianetti E; Montanelli L; Vitti P; Pinchera A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):712-8. PubMed ID: 17697008
[TBL] [Abstract][Full Text] [Related]
32. Effects of mutations involving cysteine residues distal to the S281HCC motif at the C-terminus on the functional characteristics of a truncated ectodomain-only thyrotropin receptor anchored on glycosylphosphatidyl-inositol.
Ho SC; Goh SS; Li S; Khoo DH; Paterson M
Thyroid; 2008 Dec; 18(12):1313-9. PubMed ID: 18976165
[TBL] [Abstract][Full Text] [Related]
33. The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor.
Rossi M; Dimida A; Dell'anno MT; Trincavelli ML; Agretti P; Giorgi F; Corsini GU; Pinchera A; Vitti P; Tonacchera M; Maggio R
J Pharmacol Exp Ther; 2007 Jan; 320(1):465-74. PubMed ID: 17062616
[TBL] [Abstract][Full Text] [Related]
34. Small-molecule thyrotropin receptor agonist activates naturally occurring thyrotropin-insensitive mutants and reveals their distinct cyclic adenosine monophosphate signal persistence.
Allen MD; Neumann S; Gershengorn MC
Thyroid; 2011 Aug; 21(8):907-12. PubMed ID: 21745101
[TBL] [Abstract][Full Text] [Related]
35. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5.
Karges B; Krause G; Homoki J; Debatin KM; de Roux N; Karges W
J Endocrinol; 2005 Aug; 186(2):377-85. PubMed ID: 16079263
[TBL] [Abstract][Full Text] [Related]
36. TSH induces co-localization of TSH receptor and Na/K-ATPase in human erythrocytes.
Balzan S; Del Carratore R; Nicolini G; Forini F; Lubrano V; Simili M; Benedetti PA; Iervasi G
Cell Biochem Funct; 2009 Jul; 27(5):259-63. PubMed ID: 19466745
[TBL] [Abstract][Full Text] [Related]
37. Antibody-induced modulation of TSH receptor post-translational processing.
Ando T; Latif R; Davies TF
J Endocrinol; 2007 Oct; 195(1):179-86. PubMed ID: 17911409
[TBL] [Abstract][Full Text] [Related]
38. Techniques to quantify TSH receptor antibodies.
Ajjan RA; Weetman AP
Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):461-8. PubMed ID: 18574503
[TBL] [Abstract][Full Text] [Related]
39. Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.
Haas AK; Kleinau G; Hoyer I; Neumann S; Furkert J; Rutz C; Schülein R; Gershengorn MC; Krause G
Cell Mol Life Sci; 2011 Jan; 68(1):159-67. PubMed ID: 20652618
[TBL] [Abstract][Full Text] [Related]
40. [Pathologic manifestations of hormonal receptor mutations].
Milgrom E
Bull Acad Natl Med; 2000; 184(3):605-16; discussion 617-9. PubMed ID: 10989556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]